---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-26-000024"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2026-06-29T20:14:37+00:00"
generated_at: "2026-06-29T20:16:27.953055+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics annual meeting: three directors face over 1.8M withheld votes

## Summary
- Stockholders elected 7 directors; Srinivas Akkaraju, Raymond Cheong, Daniel Spiegelman each received >1.8M withheld votes.
- Fahed Al Marzooqi and Richard S. Nelson received strong support (2.4M for, 264K withheld).
- Ratification of Ernst & Young as auditor passed with 99.9% for (2,964,869 for, 1,952 against).
- Advisory say-on-pay vote: 686,535 for, 5,291 against, and 1,967,329 abstentions (310,535 broker non-votes).

## SEC filing metadata
- accession: 0001641489-26-000024
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2026-06-29T20:14:37+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148926000024/0001641489-26-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148926000024/vtvt-20260626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-26-000024
- JSON: https://secwatch.observer/filing/0001641489-26-000024.json
- Plain text: https://secwatch.observer/filing/0001641489-26-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
